Precision Biosciences (DTIL) FCF Margin (QoQ) (2018 - 2026)
Precision Biosciences (DTIL) FCF Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.03 Bn | 131.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.64 Bn | 77.64 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn |
| 4 | Moderna | 57.93 Bn | 52.80 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.95 Bn | 36.86 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.51 Bn | 28.20 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.00 Bn | 9.60 Bn | 668.28 Mn |
| 8 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - |
| 10 | Precision Biosciences | 228.44 Mn | 140.89 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,736.00 |
| Dec 31, 2025 | 11.74 Mn |
| Sep 30, 2025 | -483,376.00 |
| Jun 30, 2025 | -4.67 Mn |
| Mar 31, 2025 | -6.30 Mn |
| Dec 31, 2024 | -191,041.00 |
| Sep 30, 2024 | -100,330.00 |
| Jun 30, 2024 | 7,858.00 |
| Mar 31, 2024 | 1,088.00 |
| Dec 31, 2023 | 5,965.00 |
| Sep 30, 2023 | -6,672.00 |
| Jun 30, 2023 | 25,206.00 |
| Mar 31, 2023 | -15,223.00 |
| Dec 31, 2022 | -59,365.00 |
| Sep 30, 2022 | 103,611.00 |
| Jun 30, 2022 | 24,056.00 |
| Mar 31, 2022 | -49,777.00 |
| Dec 31, 2021 | -29,481.00 |
| Sep 30, 2021 | -5,450.00 |
| Jun 30, 2021 | -45,749.00 |